144 related articles for article (PubMed ID: 25036747)
1. Targeting the immune system to treat hypertension: where are we?
Gooch JL; Sharma AC
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):473-9. PubMed ID: 25036747
[TBL] [Abstract][Full Text] [Related]
2. Relevance of Immune-Sympathetic Nervous System Interplay for the Development of Hypertension.
Winklewski PJ; Radkowski M; Demkow U
Adv Exp Med Biol; 2016; 884():37-43. PubMed ID: 26453069
[TBL] [Abstract][Full Text] [Related]
3. The immune system in hypertension.
Harrison DG
Trans Am Clin Climatol Assoc; 2014; 125():130-38; discussion 138-40. PubMed ID: 25125726
[TBL] [Abstract][Full Text] [Related]
4. Novel Pathophysiological Mechanisms in Hypertension.
Samson R; Lee A; Lawless S; Hsu R; Sander G
Adv Exp Med Biol; 2017; 956():21-35. PubMed ID: 27981434
[TBL] [Abstract][Full Text] [Related]
5. Cytokine networking of innate immunity cells: a potential target of therapy.
Striz I; Brabcova E; Kolesar L; Sekerkova A
Clin Sci (Lond); 2014 May; 126(9):593-612. PubMed ID: 24450743
[TBL] [Abstract][Full Text] [Related]
6. Role of the immune system in hypertensive target organ damage.
Kvakan H; Luft FC; Muller DN
Trends Cardiovasc Med; 2009 Oct; 19(7):242-6. PubMed ID: 20382349
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective.
Murray EC; Nosalski R; MacRitchie N; Tomaszewski M; Maffia P; Harrison DG; Guzik TJ
Cardiovasc Res; 2021 Nov; 117(13):2589-2609. PubMed ID: 34698811
[TBL] [Abstract][Full Text] [Related]
8. Targeting cytokine signaling in salt-sensitive hypertension.
Crowley SD; Jeffs AD
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1153-F1158. PubMed ID: 27558557
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-23/interleukin-17 axis in T-cell-mediated actions in hypertension.
Higaki A; Mahmoud AUM; Paradis P; Schiffrin EL
Cardiovasc Res; 2021 Apr; 117(5):1274-1283. PubMed ID: 32870976
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Immunity and Hypertension.
Lopez Gelston CA; Mitchell BM
Am J Hypertens; 2017 Jul; 30(7):643-652. PubMed ID: 28200062
[TBL] [Abstract][Full Text] [Related]
11. The immune system in hypertension.
Trott DW; Harrison DG
Adv Physiol Educ; 2014 Mar; 38(1):20-4. PubMed ID: 24585465
[TBL] [Abstract][Full Text] [Related]
12. Immune-related effects in hypertension and target-organ damage.
Muller DN; Kvakan H; Luft FC
Curr Opin Nephrol Hypertens; 2011 Mar; 20(2):113-7. PubMed ID: 21245763
[TBL] [Abstract][Full Text] [Related]
13. Hypertension: a new treatment for an old disease? Targeting the immune system.
Bomfim GF; Cau SBA; Bruno AS; Fedoce AG; Carneiro FS
Br J Pharmacol; 2019 Jun; 176(12):2028-2048. PubMed ID: 29969833
[TBL] [Abstract][Full Text] [Related]
14. The role of Immunity in Fabry Disease and Hypertension: A Review of a Novel Common Pathway.
Del Pinto R; Ferri C
High Blood Press Cardiovasc Prev; 2020 Dec; 27(6):539-546. PubMed ID: 33047250
[TBL] [Abstract][Full Text] [Related]
15. Improving blood pressure control rates by optimizing combination antihypertensive therapy.
Epstein BJ
Expert Opin Pharmacother; 2010 Aug; 11(12):2011-26. PubMed ID: 20590485
[TBL] [Abstract][Full Text] [Related]
16. [Hypertension and the sympathetic nervous system - recent developments in research and treatment].
Grisk O
Dtsch Med Wochenschr; 2009 Nov; 134(45):2289-93. PubMed ID: 19876804
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in immunosuppressive therapy for prevention of renal allograft rejection.
Lunsford KE; Barbas AS; Brennan TV
Curr Opin Organ Transplant; 2011 Aug; 16(4):390-7. PubMed ID: 21666473
[TBL] [Abstract][Full Text] [Related]
18. Novel strategies and targets for the management of hypertension.
Taylor DA; Abdel-Rahman AA
Adv Pharmacol; 2009; 57():291-345. PubMed ID: 20230765
[TBL] [Abstract][Full Text] [Related]
19. Improving hypertension treatment. Where should we put our efforts: new drugs, new concepts, or new management?
Ménard J
Am J Hypertens; 1992 Dec; 5(12 Pt 2):252S-258S. PubMed ID: 1290621
[TBL] [Abstract][Full Text] [Related]
20. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
Tempelhof MW
South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423
[No Abstract] [Full Text] [Related]
[Next] [New Search]
